Written question asked by Brandon Lewis (Conservative) on Wednesday, 6 December 2023, in the House of Commons. It was due for an answer on Tuesday, 12 December 2023 (named day). It was answered by Andrew Stephenson (Conservative) on Tuesday, 12 December 2023 on behalf of the Department of Health and Social Care.
Pancreatin
- Question
-
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help secure the supply of Creon 25000 for patients ordinarily prescribed that pharmaceutical.
- Answer
-
The Department was made aware of a short-term supply issue with Creon 25000 gastro-resistant capsules, in September and November 2023. The supplier has since confirmed that it is back in stock, and we are not aware of any further issues with supply of Creon.
The Department has well-established processes for managing and mitigating medicine supply issues, which involve working with the pharmaceutical industry, the Medicines and Healthcare products Regulatory Agency, NHS England, the devolved governments, and others operating in the supply chain to help ensure patients have access to the treatments they need.
Secondary information
- Type
- Written question
- Reference
- 5556
- Session
- 2023-24
- Subjects
- Pancreatic enzyme replacement therapy
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-12-14 08:48:52 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/5556
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/5556
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2023-24/5556